CHEBI:95071 - pracinostat

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name pracinostat
ChEBI ID CHEBI:95071
Definition A hydroxamic acid that is N-hydroxyacrylamide which is substituted at position 3 by a 2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl group (the E isomer). An orally available pan-histone deacetylase inhibitor with demonstrated activity in the treatment of advanced solid tumours.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C20H30N4O2
Net Charge 0
Average Mass 358.486
Monoisotopic Mass 358.23688
InChI InChI=1S/C20H30N4O2/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25)/b12-10+
InChIKey JHDKZFFAIZKUCU-ZRDIBKRKSA-N
SMILES CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)/C=C/C(=O)NO
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): EC 3.5.1.98 (histone deacetylase) inhibitor
An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the function of histone deacetylase (EC 3.5.1.98).
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
antimalarial
A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
antimalarial
A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing pracinostat (CHEBI:95071) has role antimalarial (CHEBI:38068)
pracinostat (CHEBI:95071) has role antineoplastic agent (CHEBI:35610)
pracinostat (CHEBI:95071) has role apoptosis inducer (CHEBI:68495)
pracinostat (CHEBI:95071) has role EC 3.5.1.98 (histone deacetylase) inhibitor (CHEBI:61115)
pracinostat (CHEBI:95071) is a benzimidazole (CHEBI:36622)
pracinostat (CHEBI:95071) is a hydroxamic acid (CHEBI:24650)
pracinostat (CHEBI:95071) is a olefinic compound (CHEBI:78840)
pracinostat (CHEBI:95071) is a tertiary amino compound (CHEBI:50996)
IUPAC Name
(2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide
INNs Sources
pracinostat WHO MedNet
pracinostat WHO MedNet
pracinostat ChemIDplus
pracinostatum WHO MedNet
Synonyms Sources
SB 939 ChemIDplus
SB-939 ChemIDplus
SB939 ChemIDplus
Manual Xrefs Databases
DB05223 DrugBank
LSM-43290 LINCS
Pracinostat Wikipedia
View more database links
Registry Number Type Source
929016-96-6 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
21873472 PubMed citation Europe PMC
22475363 PubMed citation Europe PMC
22508312 PubMed citation Europe PMC
23556431 PubMed citation Europe PMC
23893953 PubMed citation Europe PMC
25632070 PubMed citation Europe PMC
25983041 PubMed citation Europe PMC
26853619 PubMed citation Europe PMC
27196751 PubMed citation Europe PMC
27855304 PubMed citation Europe PMC
28094841 PubMed citation Europe PMC
28301600 PubMed citation Europe PMC
28841236 PubMed citation Europe PMC
30181244 PubMed citation Europe PMC
30632841 PubMed citation Europe PMC
30760466 PubMed citation Europe PMC
30841499 PubMed citation Europe PMC
30932330 PubMed citation Europe PMC
31468521 PubMed citation Europe PMC
31526347 PubMed citation Europe PMC
31527052 PubMed citation Europe PMC
Last Modified
13 November 2019